SRNE
Sorrento Therapeutics Inc
Price:  
0.31 
USD
Volume:  
176,993,280.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRNE EV/EBITDA

-274956.4%
Upside

As of 2024-10-05, the EV/EBITDA ratio of Sorrento Therapeutics Inc (SRNE) is -0.22. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SRNE's latest enterprise value is 74.38 mil USD. SRNE's TTM EBITDA according to its financial statements is -340.66 mil USD. Dividing these 2 quantities gives us the above SRNE EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.3x - 17.4x 13.9x
Forward P/E multiples 17.6x - 20.5x 17.7x
Fair Price (940.64) - (930.09) (844.63)
Upside -306196.9% - -302763.9% -274956.4%
0.31 USD
Stock Price
(844.63) USD
Fair Price

SRNE EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-10-04 -0.21
2024-10-03 -0.21
2024-10-02 -0.21
2024-10-01 -0.21
2024-09-30 -0.21
2024-09-27 -0.21
2024-09-26 -0.21
2024-09-25 -0.21
2024-09-24 -0.21
2024-09-23 -0.21
2024-09-20 -0.21
2024-09-19 -0.21
2024-09-18 -0.21
2024-09-17 -0.21
2024-09-16 -0.21
2024-09-13 -0.21
2024-09-12 -0.21
2024-09-11 -0.21
2024-09-10 -0.21
2024-09-09 -0.21
2024-09-06 -0.21
2024-09-05 -0.21
2024-09-04 -0.21
2024-09-03 -0.21
2024-08-30 -0.21
2024-08-29 -0.21
2024-08-28 -0.21
2024-08-27 -0.21
2024-08-26 -0.21
2024-08-23 -0.21
2024-08-22 -0.21
2024-08-21 -0.21
2024-08-20 -0.21
2024-08-19 -0.21
2024-08-16 -0.21
2024-08-15 -0.21
2024-08-14 -0.21
2024-08-13 -0.21
2024-08-12 -0.21
2024-08-09 -0.21
2024-08-08 -0.21
2024-08-07 -0.21
2024-08-06 -0.21
2024-08-05 -0.21
2024-08-02 -0.21
2024-08-01 -0.21
2024-07-31 -0.21
2024-07-30 -0.21
2024-07-29 -0.21
2024-07-26 -0.21